Tag: Wilson Sonsini

Market and clients alike bear witness: which Chinese and international law firms have truly stood out?

Pharmaceutical R&D company WuXi AppTec issues RMB6.78 billion (USD996.6 million) in USD-settled zero-coupon convertible bonds due in 2027

Wilson Sonsini has appointed Jocelyn Chow as a partner in Hong Kong, bolstering the firm’s capabilities in national security and antitrust matters

WuXi AppTec has sold its China clinical research services business to Hillhouse Investment

Which Chinese and international law firms have earned client trust through exceptional expertise?          

Wilson Sonsini hires Chu Yang as corporate partner in Hong Kong to bolster its Asian team after recent departures

Wilson Sonsini, based in Silicon Valley, confirms closing its Beijing office after deciding not to renew its lease

China Business Law Journal reveals its top performing law firms of 2023  

Great leadership is irreplaceable, especially in tough market conditions, guiding law firms and young talent through adversity

Amid the cool capital markets climate, the recent surge in billion-dollar M&A deals involving overseas biomedical companies

When helping clients navigate a complex legal landscape, young elite lawyers have brought fresh ideas and innovative approaches to the table

Wilson Sonsini, Harneys and Loeb & Loeb has assisted on BitFuFu’s merger with SPAC Arisz Acquisition to list on the Nasdaq

Law firms Kirkland & Ellis, Ogier, Han Kun, Wilson Sonsini, and Maples Group advise on Webull's USD7.3bn SPAC listing with a blank-cheque firm on Nasdaq

Fangda Partners, Wilson Sonsini, Maples Group, Davis Polk and Jingtian & Gongcheng advised Chinese medical research group WuXi XDC on a spin-off listing

Seven law firms represented the stakeholders on a merger between car insurance company CheChe Technology and blank-cheque enterprise Prime Impact, marking the latest Chinese variable interest entity (VIE) to pursue an overseas listing

China Business Law Journal reveals its top performing law firms of 2022    

Cross-border e-commerce company Zibuyu in an unusual move engaged five compliance legal advisers on its HKD275 million listing on the HKEX

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

The leaders of international and domestic firms in China have their eyes firmly on the prizes of the future

Electric-vehicle maker and auto-design service company CH-AUTO agreed a merger with special-purpose acquisition company Mountain Crest IV worth nearly USD1.7 billion